Add to ORKGThe expanded ability to detect myocardial injury using very sensi-tive and specific biomarker assays has been a major factor in the evolution of the definition of acute myocardial infarction (MI). This is clearly evident in the ‘Universal Definition of Myocardial Infarction ’ recently developed by a joint task force of experts o
Background: The introduction of more sensitive cardiac troponin assays has led to increased recognit...
Over the past decade, there has been a progressive evolution of cardiac marker testing in patients w...
The advent of the measurement of cardiac troponins, cardiac troponin T and cardiac troponin I, offer...
The expanded ability to detect myocardial injury using very sensi-tive and specific biomarker assays...
Myocardial Infarction (AMI) was recently published (1). The guidelines expand on previous informatio...
In 1979, the WHO defined 3 specific criteria for use in the diagnosis of myocardial infarction (MI)3...
To assess the diagnostic accuracy of troponin I (TnI) elevation in patients with acute coronary synd...
The diagnosis of myocardial infarction (MI) depends on a rise and/or fall of cardiac biomarkers such...
Objective: To discuss the more controversial clinical and laboratory aspects in the application of t...
© 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.Trop...
The development of newer-generation troponin as-says has led to remarkable progress in the rapid dia...
Cardiovascular diseases are leading cause of morbidity in the world. Measurement of the level of bio...
The recent document of the ESC/ACC Committee for the redefinition of myocardial infarction (MI) has ...
It has become good scientific practice to mention po-tential conflicts at the beginning of the prese...
The recent document of the ESC/ACC Committee for the redefinition of myocardial infarction (MI) has ...
Background: The introduction of more sensitive cardiac troponin assays has led to increased recognit...
Over the past decade, there has been a progressive evolution of cardiac marker testing in patients w...
The advent of the measurement of cardiac troponins, cardiac troponin T and cardiac troponin I, offer...
The expanded ability to detect myocardial injury using very sensi-tive and specific biomarker assays...
Myocardial Infarction (AMI) was recently published (1). The guidelines expand on previous informatio...
In 1979, the WHO defined 3 specific criteria for use in the diagnosis of myocardial infarction (MI)3...
To assess the diagnostic accuracy of troponin I (TnI) elevation in patients with acute coronary synd...
The diagnosis of myocardial infarction (MI) depends on a rise and/or fall of cardiac biomarkers such...
Objective: To discuss the more controversial clinical and laboratory aspects in the application of t...
© 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.Trop...
The development of newer-generation troponin as-says has led to remarkable progress in the rapid dia...
Cardiovascular diseases are leading cause of morbidity in the world. Measurement of the level of bio...
The recent document of the ESC/ACC Committee for the redefinition of myocardial infarction (MI) has ...
It has become good scientific practice to mention po-tential conflicts at the beginning of the prese...
The recent document of the ESC/ACC Committee for the redefinition of myocardial infarction (MI) has ...
Background: The introduction of more sensitive cardiac troponin assays has led to increased recognit...
Over the past decade, there has been a progressive evolution of cardiac marker testing in patients w...
The advent of the measurement of cardiac troponins, cardiac troponin T and cardiac troponin I, offer...